Developing neural stem cell-based treatments for neurodegenerative diseases

被引:0
作者
James A Byrne
机构
[1] University of California,Department of Molecular and Medical Pharmacology, 650 Charles E. Young Drive South, 23–120 Center for Health Sciences
[2] University of California,Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, 615 Charles E. Young Drive South
来源
Stem Cell Research & Therapy | / 5卷
关键词
Amyotrophic Lateral Sclerosis; Neural Stem Cell; Insertional Mutagenesis; Murine Brain; Human Induce Pluripotent Stem Cell;
D O I
暂无
中图分类号
学科分类号
摘要
Owing to the aging of the population, our society now faces an impending wave of age-related neurodegenerative pathologies, the most significant of which is Alzheimer’s disease. Currently, no effective therapies for Alzheimer’s disease have been developed. However, recent advances in the fields of neural stem cells and human induced pluripotent stem cells now provide us with the first real hope for a cure. The recent discovery by Blurton-Jones and colleagues that neural stem cells can effectively deliver disease-modifying therapeutic proteins throughout the brains of our best rodent models of Alzheimer’s disease, combined with recent advances in human nuclear reprogramming, stem cell research, and highly customized genetic engineering, may represent a potentially revolutionary personalized cellular therapeutic approach capable of effectively curing, ameliorating, and/or slowing the progression of Alzheimer’s disease.
引用
收藏
相关论文
共 89 条
[1]  
Blurton-Jones M(2014)Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models Stem Cell Res Ther 5 46-1031
[2]  
Spencer B(2002)Demography. Broken limits to life expectancy Science 296 1029-1122
[3]  
Michel S(2003)Alzheimer disease in the US population: prevalence estimates using the 2000 census Arch Neurol 60 1119-69
[4]  
Castello NA(2006)Neural stem cells transplantation in cortex in a mouse model of Alzheimer’s disease J Med Invest 53 61-68
[5]  
Agazaryan AA(2009)Transplantation of primed or unprimed mouse embryonic stem cell-derived neural precursor cells improves cognitive function in Alzheimerian rats Differentiation 78 59-1555
[6]  
Davis RP(1992)Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson’s disease N Engl J Med 327 1549-292
[7]  
Müller F(2013)Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a nonhuman primate Stem Cell Reports 1 283-undefined
[8]  
Loring JF(2013)Resolving clinical hurdles for autologous pluripotent stem cell-based therapies OA Stem Cells 1 3-undefined
[9]  
Masliah E(2013)Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status Stem Cell Res Ther 4 87-undefined
[10]  
LaFerla FM(2013)Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurological function in a rat model of middle cerebral artery occlusion Stem Cell Res Ther 4 73-undefined